With extensive expertise in the technology and healthcare sectors, the fund manager has successfully executed over 50 deals across Europe and North America. His strategic style is characterized by a data-driven approach, allowing for informed decision-making during the growth and expansion phases of portfolio companies. Notable exits such as a high-value acquisition in the biotech space showcase his ability to identify lucrative opportunities. Committed to fostering innovation, he actively engages with early-stage ventures to drive long-term success.